Table 2.

Factors Associated With Progression.^a

	Univariate analysis		Multivariate analysis
	HR (95% CI)	P value	HR (95% CI)	P value
Gender (male vs female)	1.945 (1.046-3.616)	.036	1.892 (1.008-3.553)	.047
Age, years (>60 vs ≤60)	0.894 (0.523-1.527)	.681
Rescue therapy (TACL-ECF vs Sorafenib)	0.879 (0.519-1.488)	.630
Child-Pugh class (B/A)	1.084 (0.584-2.011)	.798
BCLC stage (C/B)	1.957 (1.121-3.416)	.018	1.925 (1.098-3.373)	.022
Serum AFP, ng/mL (>200 vs ≤200)	1.167 (0.697-1.954)	.557

Abbreviations: AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HR, hazard ratio.

^a Cox proportional hazards model.